$55.55 -0.41 (%) Bristol-Myers Squibb Co - New York Stock Exchange, Inc.

Dec. 5, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF

    TalkMarkets | Nov. 28, 2016 | 11:59AM EST
  2. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets | Nov. 23, 2016 | 11:45AM EST
  3. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets | Nov. 18, 2016 | 08:30AM EST
  4. Calithera Pharma In Focus Part 1 - Checkpoint Inhibition

    TalkMarkets | Nov. 16, 2016 | 07:21AM EST
  5. AskSlim Market Week - 11/11/16

    TalkMarkets | Nov. 11, 2016 | 22:29PM EST
  6. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets | Nov. 9, 2016 | 23:23PM EST
  7. Trump Triumphs

    TalkMarkets | Nov. 9, 2016 | 21:28PM EST
  8. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  9. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets | Nov. 7, 2016 | 10:20AM EST
  10. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 18:49PM EST
  11. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  12. Surviving Hillary - Surviving Donald: The Election Portfolio

    TalkMarkets | Oct. 31, 2016 | 15:10PM EST
  13. Daily Update: Core Durable Goods Down 21 Straight Months

    TalkMarkets | Oct. 27, 2016 | 11:55AM EST
  14. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets | Oct. 26, 2016 | 20:45PM EST
  15. 5 Stocks To Watch Before The Market Opens Tomorrow (October 27, 2016)

    TalkMarkets | Oct. 26, 2016 | 16:50PM EST
  16. Big Pharma’s Big Biotech Problem

    Dividend.com | Oct. 12, 2016 | 08:00AM EST
  17. Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data

    TalkMarkets | Oct. 10, 2016 | 18:35PM EST
  18. Earnings ESP

    TalkMarkets | Oct. 8, 2016 | 18:11PM EST
  19. Rayno 2016 Life Science Portfolio Update

    TalkMarkets | Sep. 29, 2016 | 20:14PM EST
  20. The Gap Inc. Leads 85 Stocks Going Ex-Dividend Next Week

    Dividend.com | Sep. 29, 2016 | 09:00AM EST
  21. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
  22. Trending on Dividend.com: Bristol-Myers Disappoints and DHT Surprises, While Wal-Mart Starts Race After Amazon

    Dividend.com | Aug. 12, 2016 | 15:00PM EST
  23. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily | Jul. 28, 2016 | 09:30AM EST
  24. Amazon, Alphabet, Baidu, Ford, Celgene On Tap Thursday

    Investors Business Daily | Jul. 27, 2016 | 16:45PM EST
  25. Investing Action Plan: Amazon, Alphabet, Baidu, Ford, Celgene

    Investors Business Daily | Jul. 27, 2016 | 12:51PM EST
  26. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 07:00AM EST
  27. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 12:57PM EST
  28. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus | Jul. 11, 2016 | 04:31AM EST
  29. Bristol-Myers Looks To A Promising Future

    Benzinga | Feb. 17, 2016 | 08:17AM EST
  30. Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark And More

    Benzinga | Feb. 14, 2016 | 14:09PM EST
  31. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
  32. Earnings Recap For January 28

    Benzinga | Jan. 28, 2016 | 16:34PM EST
  33. Bristol Myers Ticks Higher Following Q4 Beat, Encouraging Guidance

    Benzinga | Jan. 28, 2016 | 07:54AM EST
  34. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  35. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga | Jan. 25, 2016 | 11:43AM EST
  36. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga | Jan. 25, 2016 | 10:25AM EST
  37. Benzinga's Top Downgrades

    Benzinga | Jan. 25, 2016 | 09:30AM EST
  38. Bristol-Myers Squibb's Opdivo + Yervoy Receives Expanded FDA Approval in Unresectable or Metastatic Melanoma Across BRAF Status1

    Benzinga | Jan. 24, 2016 | 06:55AM EST
  39. Benzinga's Top Upgrades

    Benzinga | Jan. 22, 2016 | 08:50AM EST
  40. Fast Money Traders Share Their Biotech Picks

    Benzinga | Jan. 12, 2016 | 07:14AM EST
  41. Dual Therapeutics Announces Oncology Strategic Collaboration With Bristol-Myers Squibb

    GuruFocus | Jan. 8, 2016 | 23:04PM EST
  42. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD | Jan. 8, 2016 | 15:34PM EST
  43. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  44. Lilly Guidance Misses Estimates On Lower Sales

    IBD | Jan. 5, 2016 | 13:18PM EST
  45. Baxalta Cuts Cancer Deal As Shire Circles Nearer

    IBD | Jan. 4, 2016 | 12:52PM EST
  46. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus | Dec. 24, 2015 | 15:44PM EST
  47. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD | Dec. 18, 2015 | 14:05PM EST
  48. Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare for $350M Upfront Plus Milestone Payments

    Benzinga | Dec. 18, 2015 | 04:17AM EST
  49. Strategic Beta ETFs Among Year's Top Performers

    IBD | Dec. 15, 2015 | 19:12PM EST
  50. Fast Money Picks For December 15

    Benzinga | Dec. 15, 2015 | 07:18AM EST
Trading Center